What tells the influenza polymerase to stop transcribing and start replicating?
Influenza A virus carries one heterotrimeric RNA-dependent RNA polymerase and asks it to do two incompatible things on the same eight templates. Early in infection the enzyme makes capped and polyadenylated messenger RNA, which requires it to stay bound in cis to the 5 prime end of the template, since that association is also what forces the stuttering at the poly-uridine track that builds the tail. Later the same enzyme must synthesise full-length genomes, which is primer independent and demands that it read through the very ends it was holding onto. Perez 2010 states the paradox directly and notes that the models then available did not reconcile it. The field had correlates for the transition, including stabilisation of the complementary RNA intermediate, nucleotide concentration, and the soluble pools of nucleoprotein and polymerase, but no molecular event that reassigned the enzyme.
Perez 2010 deep sequenced the sub-40 nucleotide RNA fraction of infected lung epithelial cells and found a discrete species, named svRNA, matching the 5 prime terminus of each of the eight genomic segments at 22 to 27 nucleotides. It was not distributed across the genome the way breakdown products were, it was made by H1N1, H3N2 and H5N1 in eggs and by H1N1 in human, canine and murine cells, and it was not induced by an unrelated virus or by type I interferon. Production from the eight bidirectional plasmids required the three polymerase subunits, nucleoprotein and segment 8, with NEP rather than NS1 supplying the segment 8 contribution, and a synthetic 5 prime triphosphorylated mimetic co-precipitated only with the assembled trimer. Locked nucleic acid inhibition of one segment's svRNA reduced that segment's genomic RNA and viral titres while leaving messenger and complementary RNA and the other segments intact.
That paper did not show how svRNA is made or that it causes the switch, and it says so. Perez 2012 supplied much of what was missing. Small viral RNA is templated from the complementary RNA intermediate, which is why the NEP requirement disappears when a complementary-sense template is provided directly. It stays nuclear and is largely excluded from virions. It binds through the PB1 and PA heterodimer, with the basic residue R566 of PA most important. In a cell-free reaction with purified trimer and a complementary RNA minireplicon, synthetic svRNA promoted full-length synthesis even when its 3 prime hydroxyl was blocked, which excludes priming, and the first 13 nucleotides sufficed. A recombinant virus carrying a poly-uridine track substitution in the neuraminidase segment lost genome synthesis for that segment alone while keeping neuraminidase messenger RNA. Perez 2012 states in its discussion that this is the first example of a small RNA controlling RNA-dependent RNA polymerase activity, a priority claim made by that paper.
The two Perez papers turn the switch into a ligand-occupancy question rather than only a question of protein and nucleotide concentrations. The interpretation built on top of that, that each segment carries its own svRNA-loaded replicase and that this is how the eight segments are kept in balance, is consistent with the single-segment defect but is not established by any direct measurement of polymerase occupancy, and no structure of the complex exists in either paper. Perez 2012 itself cautions that the promiscuity of a short synthetic svRNA in vitro may not reflect what the virus uses in a cell.
The line did not continue as a dedicated programme in this corpus. Its most direct later appearance is in Nilsson-Payant 2021, where svRNA is visible as a distinct species alongside the mini-viral RNA that accumulates when nucleoprotein is scarce, which places the two short products side by side without resolving how they relate.
Morales 2017 carries the svRNA concept to another virus family, and it is led by the Enjuanes and Sola group in Madrid with the tenOever contribution given as reagents, conceptual advice and manuscript writing. It identified three small RNAs from SARS-CoV during infection of mouse lung, two from nsp3 and one from the nucleocapsid gene, made independently of Drosha and Dicer, and blocking the nucleocapsid-derived species with an intranasal locked nucleic acid reduced lung pathology and inflammatory cytokines without lowering lung titres. The important point for this theme is the contrast rather than the continuity. Influenza svRNAs come from noncoding segment ends and act on the viral life cycle, whereas these coronavirus species come from coding regions and act on host pathology, with no endogenous target identified. Reading the two together indicates that virus-derived small RNAs serve different purposes in different families, which is a synthesis available only across the papers.
Perez 2010 is the identification and the functional perturbation. Perez 2012 is the mechanism, the binding site and the segment-specificity test. Morales 2017 is the collaborative extension to a coronavirus, and its findings belong to the Madrid group.
The requirement for NEP in svRNA production ties this theme directly to the splicing theme, since the segment 8 splice site is what paces NEP accumulation in Chua 2013, and Chua 2013 cites the transcription to replication switch as the event that NEP accumulation is likely to trigger. The theme also connects to the nucleoprotein work, because Perez 2010 and Perez 2012 approach the switch by adding a small RNA while Nilsson-Payant 2021 approaches the same polymerase by removing its elongation factor, and both read out short products on a promoter-directed Northern blot. Beyond this area, the small RNA methods used here recur across the laboratory's work on small RNA antiviral defence.
SARS-CoV generates three discrete small viral RNAs during infection of mouse lung, and blocking the one derived from the nucleocapsid gene with a locked nucleic acid antagomir reduces pulmonary inflammation, tissue damage and proinflammatory cytokine expression without measurably lowering lung virus titres.
Influenza A virus small viral RNAs are shown to be synthesized from the complementary RNA intermediate, to load into the RNA binding cleft of the polymerase PA subunit, and to act there as segment-specific allosteric enhancers of full-length genome synthesis.
Influenza A virus produces a family of 22 to 27 nucleotide small viral RNAs corresponding to the 5 prime end of each genomic segment, which accumulate as the polymerase shifts toward genome synthesis and whose inhibition selectively depletes genomic RNA without comparably affecting messenger or complementary RNA.